Literature DB >> 8354928

Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis.

V L Di Ninno, J W Cherwanogrodzky, J P Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8354928     DOI： 10.1093/infdis/168.3.793

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.

Authors:  J Conley; H Yang; T Wilson; K Blasetti; V Di Ninno; G Schnell; J P Wong
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

2.  Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.

Authors:  Karleigh A Hamblin; Stuart J Armstrong; Kay B Barnes; Carwyn Davies; Jonathan P Wong; James D Blanchard; Sarah V Harding; Andrew J H Simpson; Helen S Atkins
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

3.  Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.

Authors:  I A Bakker-Woudenberg; M T ten Kate; L Guo; P Working; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.

Authors:  M S Webb; N L Boman; D J Wiseman; D Saxon; K Sutton; K F Wong; P Logan; M J Hope
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.

Authors:  Irma A J M Bakker-Woudenberg; Marian T ten Kate; Luke Guo; Peter Working; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 6.  The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy.

Authors:  Karleigh A Hamblin; Jonathan P Wong; James D Blanchard; Helen S Atkins
Journal:  Front Cell Infect Microbiol       Date:  2014-06-18       Impact factor: 5.293

Review 7.  Development of Liposomal Ciprofloxacin to Treat Lung Infections.

Authors:  David Cipolla; Jim Blanchard; Igor Gonda
Journal:  Pharmaceutics       Date:  2016-03-01       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.